Solar urticaria caused by visible light in a 33-year-old male refractory to treatment with omalizumab

Photodermatol Photoimmunol Photomed. 2020 Jul;36(4):316-317. doi: 10.1111/phpp.12545. Epub 2020 Mar 21.

Authors

Ellen Wright¹, Elena Kurland², Henry W Lim²

Affiliations

¹ Chicago Medical School, Rosalind Franklin University, North Chicago, Illinois.
² Department of Dermatology, Henry Ford Hospital, Detroit, Michigan.

PMID: 32141097
DOI: 10.1111/phpp.12545

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Anti-Allergic Agents / therapeutic use
Humans
Male
Omalizumab / therapeutic use
Photosensitivity Disorders / drug therapy*
Photosensitivity Disorders / etiology
Sunlight / adverse effects*
Urticaria / drug therapy*
Urticaria / etiology

Substances

Anti-Allergic Agents
Omalizumab